QQ客服 官方微博 反馈留言

	miR-125a is upregulated in cancer stem-like cells derived from TW01 and is responsible for maintaining stemness by inhibiting p53
	Chen, Jianjun[1]; Ouyang, Hui[1]; An, Xuemei[2]; Liu, Shixi[3]
	2019
卷号	17期号:1页码:87-94
URL标识	查看原文
WOS记录号	WOS:000454845500011
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4334046
专题	成都中医药大学
作者单位	1.[1]First Peoples Hosp Neijiang, Dept ENT, Neijiang 641000, Sichuan, Peoples R China 2.[2]Chengdu Univ Tradit Chinese Med, Dept Neurol, Chengdu 610000, Sichuan, Peoples R China 3.[3]Sichuan Univ, West China Hosp, Dept ENT, 37 Guoxue Rd, Chengdu 610000, Sichuan, Peoples R China
推荐引用方式 GB/T 7714	Chen, Jianjun[1],Ouyang, Hui[1],An, Xuemei[2],et al. miR-125a is upregulated in cancer stem-like cells derived from TW01 and is responsible for maintaining stemness by inhibiting p53[J],2019,17(1):87-94.
APA	Chen, Jianjun[1],Ouyang, Hui[1],An, Xuemei[2],&Liu, Shixi[3].(2019).miR-125a is upregulated in cancer stem-like cells derived from TW01 and is responsible for maintaining stemness by inhibiting p53.,17(1),87-94.
MLA	Chen, Jianjun[1],et al."miR-125a is upregulated in cancer stem-like cells derived from TW01 and is responsible for maintaining stemness by inhibiting p53".17.1(2019):87-94.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。